Luminopia
Pioneering a new class of treatments for significant neuro-visual disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD99—148m (Dealroom.co estimates Jun 2023.)
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Grant | ||
| N/A | $11.1m | Early VC | |
$12.0m | Early VC | ||
* | $5.7m Valuation: $60.0m | Seed | |
* | $16.0m | Series A | |
| Total Funding | AUD69.3m | ||
Related Content
Recent News about Luminopia
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.